Pharmacological activation of a novel p53-dependent S-phase checkpoint involving CHK-1Alaa A. Ahmed(Johns Hopkins University), Margaret Ashcroft(Institute of Cancer Research)Cell Death and DiseaseMay 19, 201110.1038/cddis.2011.42Cited by 32SaveCiteExport RISWatch citationsRelated PapersGenome-wide CRISPR/Cas9 deletion screen defines mitochondrial gene essentiality and identifies routes for tumour cell viability in hypoxia|Communications Biology|2021|30